$7.27 Billion is the total value of HHLR ADVISORS, LTD.'s 64 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UBER | New | UBER TECHNOLOGIES INC | $375,589,000 | – | 12,326,519 | +100.0% | 5.16% | – |
| ALGN | New | ALIGN TECHNOLOGY INC | $283,230,000 | – | 1,565,500 | +100.0% | 3.89% | – |
| AMZN | New | AMAZON COM INC | $84,115,000 | – | 48,456 | +100.0% | 1.16% | – |
| NFLX | New | NETFLIX INC | $69,849,000 | – | 261,002 | +100.0% | 0.96% | – |
| CVET | New | COVETRUS INC | $47,063,000 | – | 3,958,198 | +100.0% | 0.65% | – |
| SDC | New | SMILEDIRECTCLUB INC | $40,572,000 | – | 2,923,086 | +100.0% | 0.56% | – |
| GMAB | New | GENMAB A Ssponsored ads | $30,390,000 | – | 1,500,000 | +100.0% | 0.42% | – |
| AAPL | New | APPLE INC | $28,614,000 | – | 127,759 | +100.0% | 0.39% | – |
| SQ | New | SQUARE INCcl a | $26,556,000 | – | 428,675 | +100.0% | 0.36% | – |
| ZLAB | New | ZAI LAB LTDadr | $25,815,000 | – | 798,001 | +100.0% | 0.36% | – |
| UXIN | New | UXIN LTDads | $23,126,000 | – | 9,439,181 | +100.0% | 0.32% | – |
| NIO | New | NIO INCspon ads | $20,855,000 | – | 13,368,900 | +100.0% | 0.29% | – |
| HTHT | New | HUAZHU GROUP LTDsponsored ads | $20,191,000 | – | 611,490 | +100.0% | 0.28% | – |
| MELI | New | MERCADOLIBRE INC | $17,970,000 | – | 32,600 | +100.0% | 0.25% | – |
| MRNA | New | MODERNA INC | $15,577,000 | – | 978,434 | +100.0% | 0.21% | – |
| NOAH | New | NOAH HLDGS LTDspon ads cl a | $14,052,000 | – | 481,220 | +100.0% | 0.19% | – |
| IGMS | New | IGM BIOSCIENCES INC | $6,213,000 | – | 350,000 | +100.0% | 0.08% | – |
| CJJD | New | CHINA JO-JO DRUGSTORES INC | $5,856,000 | – | 4,840,000 | +100.0% | 0.08% | – |
| TCRR | New | TCR2 THERAPEUTICS INC | $4,853,000 | – | 322,903 | +100.0% | 0.07% | – |
| TXG | New | 10X GENOMICS INC | $3,780,000 | – | 75,000 | +100.0% | 0.05% | – |
| CBMG | New | CELLULAR BIOMEDICINE GROUP I | $3,495,000 | – | 235,214 | +100.0% | 0.05% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $1,595,000 | – | 246,883 | +100.0% | 0.02% | – |
| SFUN | New | FANG HLDGS LTDadr new | $666,000 | – | 300,000 | +100.0% | 0.01% | – |
| GSAHWS | New | GS ACQUISITION HLDGS CORP*w exp 06/12/202 | $453,000 | – | 333,333 | +100.0% | 0.01% | – |
| NTGN | New | NEON THERAPEUTICS INC | $103,000 | – | 60,000 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.